Clinical Trial Update: A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating atezolizumab plus paclitaxel versus placebo plus paclitaxel in untreated locally advanced or metastatic triple-negative breast cancer h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Triple-Negative Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2021-01-07